IGF2BP3 and renal cell carcinoma: Consistently, in vivo assays revealed that IGF2BP3 knockdown attenuated the RCC cancer stemness and inhibited orthotopic xenografts growth while overexpression of circRARS impaired the inhibition (Figures 7A,B and S16A).